Sweden · Delayed Price · Currency is SEK MedCap AB Statistics
Total Valuation
MedCap AB has a market cap or net worth of SEK 9.84 billion. The enterprise value is 9.85 billion.
| Market Cap | 9.84B |
| Enterprise Value | 9.85B |
Important Dates
The last earnings date was Wednesday, July 23, 2025.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MedCap AB has 15.04 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 15.04M |
| Shares Outstanding | 15.04M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 3.87% |
| Owned by Institutions (%) | 62.66% |
| Float | 11.50M |
Valuation Ratios
The trailing PE ratio is 49.31 and the forward PE ratio is 41.00.
| PE Ratio | 49.31 |
| Forward PE | 41.00 |
| PS Ratio | 5.17 |
| PB Ratio | 7.22 |
| P/TBV Ratio | 15.42 |
| P/FCF Ratio | 32.98 |
| P/OCF Ratio | 30.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.94, with an EV/FCF ratio of 33.00.
| EV / Earnings | 49.57 |
| EV / Sales | 5.17 |
| EV / EBITDA | 27.94 |
| EV / EBIT | 40.99 |
| EV / FCF | 33.00 |
Financial Position
The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.64 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 0.95 |
| Debt / FCF | 1.12 |
| Interest Coverage | 13.05 |
Financial Efficiency
Return on equity (ROE) is 15.95% and return on invested capital (ROIC) is 9.33%.
| Return on Equity (ROE) | 15.95% |
| Return on Assets (ROA) | 7.54% |
| Return on Invested Capital (ROIC) | 9.33% |
| Return on Capital Employed (ROCE) | 13.97% |
| Revenue Per Employee | 3.26M |
| Profits Per Employee | 340,652 |
| Employee Count | 592 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 2.77 |
Taxes
In the past 12 months, MedCap AB has paid 53.00 million in taxes.
| Income Tax | 53.00M |
| Effective Tax Rate | 20.91% |
Stock Price Statistics
The stock price has increased by +8.82% in the last 52 weeks. The beta is 0.58, so MedCap AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +8.82% |
| 50-Day Moving Average | 491.34 |
| 200-Day Moving Average | 471.11 |
| Relative Strength Index (RSI) | 80.38 |
| Average Volume (20 Days) | 33,192 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedCap AB had revenue of SEK 1.90 billion and earned 198.60 million in profits. Earnings per share was 13.26.
| Revenue | 1.90B |
| Gross Profit | 1.11B |
| Operating Income | 240.20M |
| Pretax Income | 253.50M |
| Net Income | 198.60M |
| EBITDA | 314.90M |
| EBIT | 240.20M |
| Earnings Per Share (EPS) | 13.26 |
Balance Sheet
The company has 335.10 million in cash and 335.10 million in debt.
| Cash & Cash Equivalents | 335.10M |
| Total Debt | 335.10M |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.36B |
| Book Value Per Share | 90.16 |
| Working Capital | 607.40M |
Cash Flow
In the last 12 months, operating cash flow was 326.00 million and capital expenditures -27.70 million, giving a free cash flow of 298.30 million.
| Operating Cash Flow | 326.00M |
| Capital Expenditures | -27.70M |
| Free Cash Flow | 298.30M |
| FCF Per Share | 19.83 |
Margins
Gross margin is 58.16%, with operating and profit margins of 12.62% and 10.43%.
| Gross Margin | 58.16% |
| Operating Margin | 12.62% |
| Pretax Margin | 13.32% |
| Profit Margin | 10.43% |
| EBITDA Margin | 16.54% |
| EBIT Margin | 12.62% |
| FCF Margin | 15.67% |
Dividends & Yields
MedCap AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.10% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.02% |
| FCF Yield | 3.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 27, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |